These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38262165)

  • 1. The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial.
    İmamoğlu A; Stiles BJ; Jarskog LF; Pedersen CA; Elliott T; Penn DL
    J Psychiatr Res; 2024 Mar; 171():95-98. PubMed ID: 38262165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.
    Bürkner PC; Williams DR; Simmons TC; Woolley JD
    Schizophr Bull; 2017 Oct; 43(6):1291-1303. PubMed ID: 28586471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
    Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.
    Lee MR; Wehring HJ; McMahon RP; Linthicum J; Cascella N; Liu F; Bellack A; Buchanan RW; Strauss GP; Contoreggi C; Kelly DL
    Schizophr Res; 2013 Apr; 145(1-3):110-5. PubMed ID: 23415472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
    Buchanan RW; Kelly DL; Weiner E; Gold JM; Strauss GP; Koola MM; McMahon RP; Carpenter WT
    J Clin Psychopharmacol; 2017 Aug; 37(4):394-400. PubMed ID: 28590362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Halverson T; Jarskog LF; Pedersen C; Penn D
    Schizophr Res; 2019 Feb; 204():178-182. PubMed ID: 30243853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia.
    Buchanan RW; Kelly DL; Strauss GP; Gold JM; Weiner E; Zaranski J; Chen S; Blatt F; Holden J; Granholm E
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):236-243. PubMed ID: 33783399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single dose intranasal oxytocin on social cognition in schizophrenia.
    Davis MC; Lee J; Horan WP; Clarke AD; McGee MR; Green MF; Marder SR
    Schizophr Res; 2013 Jul; 147(2-3):393-7. PubMed ID: 23676253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.
    Cacciotti-Saija C; Langdon R; Ward PB; Hickie IB; Scott EM; Naismith SL; Moore L; Alvares GA; Redoblado Hodge MA; Guastella AJ
    Schizophr Bull; 2015 Mar; 41(2):483-93. PubMed ID: 24962607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia.
    Gibson CM; Penn DL; Smedley KL; Leserman J; Elliott T; Pedersen CA
    Schizophr Res; 2014 Jul; 156(2-3):261-5. PubMed ID: 24799299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.
    Pedersen CA; Gibson CM; Rau SW; Salimi K; Smedley KL; Casey RL; Leserman J; Jarskog LF; Penn DL
    Schizophr Res; 2011 Oct; 132(1):50-3. PubMed ID: 21840177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
    Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
    Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.
    Caravaggio F; Gerretsen P; Mar W; Chung JK; Plitman E; Nakajima S; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A; Menon M
    Psychoneuroendocrinology; 2017 Jul; 81():80-87. PubMed ID: 28431278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin administration enhances controlled social cognition in patients with schizophrenia.
    Woolley JD; Chuang B; Lam O; Lai W; O'Donovan A; Rankin KP; Mathalon DH; Vinogradov S
    Psychoneuroendocrinology; 2014 Sep; 47():116-25. PubMed ID: 25001961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia.
    Strauss GP; Granholm E; Holden JL; Ruiz I; Gold JM; Kelly DL; Buchanan RW
    Psychol Med; 2019 Jul; 49(10):1731-1739. PubMed ID: 30180918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.
    Feifel D; Macdonald K; Cobb P; Minassian A
    Schizophr Res; 2012 Aug; 139(1-3):207-10. PubMed ID: 22682705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin-augmented social cognitive skills training in schizophrenia.
    Davis MC; Green MF; Lee J; Horan WP; Senturk D; Clarke AD; Marder SR
    Neuropsychopharmacology; 2014 Aug; 39(9):2070-7. PubMed ID: 24637803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Verbalis JG; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
    Schizophr Res; 2016 Apr; 172(1-3):165-8. PubMed ID: 26879587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia.
    Strauss GP; Chapman HC; Keller WR; Koenig JI; Gold JM; Carpenter WT; Buchanan RW
    J Psychiatr Res; 2019 May; 112():38-43. PubMed ID: 30849617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.